08/2023

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/2023

Aug 22, 2023, 09:09 | Drugs
Neha Mehta-Shah: Absolutely honored and so grateful to receive this SIP grant to study an oral EZH2 inhibitor in CTCL.
Neha Mehta-Shah, an Associate Professor at Washington University in St. Louis, recently tweeted: "Absolutely honored…
Aug 21, 2023, 19:59 | Career
Toufic Kachaamy: The first 10 years have been a remarkable journey, and I am eager to see what the future holds as we continue to work side by side.
Toufic Kachaamy, Enterprise Clinical Leader and Interventional Program Specialist at City of Hope, stated the…
Aug 21, 2023, 18:34 | Blog
Aman Chauhan: Grateful to SWOG & NCI leadership for an opportunity to advocate for NETs therapeutic advancements on NCI’s NET task force.
Aman Chauhan, Leader Neuroendocrine Oncology and Co-Leader Radiopharmaceutical Drug Development, stated the following on LinkedIn:…
Aug 21, 2023, 18:21 | Opinion
Anne Marie Mercurio: For literally EVERYONE working in clinical trials, lose the word subject.
Anne Marie Mercurio, Patient research advocate, shared the following on twitter: "For literally EVERYONE working…
Aug 21, 2023, 17:06 | Opinion
David Entwistle: I’m delighted to join the board of directors at Redesign Health.
David Entwistle, the President and CEO of Stanford Health Care, shared on LinkedIn: "I’m delighted…
Aug 21, 2023, 17:05 | Insight
David Lubarsky: If implemented properly, AI tools could automate time-consuming nursing responsibilities.
David Lubarsky, CEO of UC Davis Health and Vice Chancellor for Human Health Sciences, shared…
Aug 21, 2023, 17:04 | Career
Gaetano Bonifacio: I'm excited to share that I started my new role as Vice President, Global Medical Affairs at GlycoMimetics.
Gaetano Bonifacio, the Vice President of Global Medical Affairs at Glycomimetics, posted the following on…
Aug 21, 2023, 17:03 | Blog
Gianrico Farrugia: We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.
Gianrico Farrugia, the President and CEO at Mayo Clinic posted on LinkedIn: "We must shift…
Aug 21, 2023, 17:03 | Insight
Talha Badar: Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, recently tweeted: "Prevalence…
Aug 21, 2023, 17:02 | Blog
David Lubarsky: Cancer diagnosis is tremendously personal, clearly – and your treatment should be too.
David Lubarsky, CEO of UC Davis Health and Vice Chancellor for Human Health Sciences, shared…
All: 539 Posts: 181 - 190
Special Coverage